Johan Wedell-Wedellsborg, Director, 10% Owner at Y-mAbs Therapeutics, Inc. (YMAB), sold 336,488 shares at $27.83 ($9.3M) on 2019-08-21, disclosed to the SEC on 2019-08-26.
Open-market sale of $9.3M YMAB by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.42 | 108,128 | $3.0M | 32.0% |
| 2 | $27.42 | 108,128 | $3.0M | 32.0% |
| 3 | $27.83 | 60,116 | $1.7M | 18.0% |
| 4 | $27.83 | 60,116 | $1.7M | 18.0% |
| Total | $27.57 avg | 336,488 | $9.3M | 100% |
| Filing → |
| YMAB | BUY | 2023-12-01 | $619K | — | Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |